JP2008509152A5 - - Google Patents

Info

Publication number

JP2008509152A5

JP2008509152A5 JP2007524998A JP2007524998A JP2008509152A5 JP 2008509152 A5 JP2008509152 A5 JP 2008509152A5 JP 2007524998 A JP2007524998 A JP 2007524998A JP 2007524998 A JP2007524998 A JP 2007524998A JP 2008509152 A5 JP2008509152 A5 JP 2008509152A5

Authority

JP

Japan

Prior art keywords

composition

taj

substance

polypeptide

human

Prior art date

2005-08-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims 27
• 108090000765 processed proteins & peptides Proteins 0.000 claims 27
• 102000004196 processed proteins & peptides Human genes 0.000 claims 27
• 239000000126 substance Substances 0.000 claims 25
• 210000002569 neuron Anatomy 0.000 claims 18
• 210000003169 central nervous system Anatomy 0.000 claims 13
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 10
• 108020004707 nucleic acids Proteins 0.000 claims 10
• 102000039446 nucleic acids Human genes 0.000 claims 10
• 150000007523 nucleic acids Chemical class 0.000 claims 10
• 208000027418 Wounds and injury Diseases 0.000 claims 6
• 125000003275 alpha amino acid group Chemical group 0.000 claims 6
• 150000001413 amino acids Chemical class 0.000 claims 6
• 230000014511 neuron projection development Effects 0.000 claims 6
• 239000000427 antigen Substances 0.000 claims 5
• 108091007433 antigens Proteins 0.000 claims 5
• 102000036639 antigens Human genes 0.000 claims 5
• 230000006378 damage Effects 0.000 claims 5
• 230000000694 effects Effects 0.000 claims 5
• 239000012634 fragment Substances 0.000 claims 5
• 208000014674 injury Diseases 0.000 claims 5
• 108091030071 RNAI Proteins 0.000 claims 4
• 230000000692 anti-sense effect Effects 0.000 claims 4
• 210000004027 cell Anatomy 0.000 claims 4
• 238000000034 method Methods 0.000 claims 4
• 230000011664 signaling Effects 0.000 claims 3
• 108060003951 Immunoglobulin Proteins 0.000 claims 2
• 238000007792 addition Methods 0.000 claims 2
• 230000000735 allogeneic effect Effects 0.000 claims 2
• 210000001130 astrocyte Anatomy 0.000 claims 2
• 230000007423 decrease Effects 0.000 claims 2
• 238000012217 deletion Methods 0.000 claims 2
• 230000037430 deletion Effects 0.000 claims 2
• 239000003814 drug Substances 0.000 claims 2
• 102000018358 immunoglobulin Human genes 0.000 claims 2
• 238000000338 in vitro Methods 0.000 claims 2
• 230000002401 inhibitory effect Effects 0.000 claims 2
• 230000000626 neurodegenerative effect Effects 0.000 claims 2
• 210000004248 oligodendroglia Anatomy 0.000 claims 2
• 230000000069 prophylactic effect Effects 0.000 claims 2
• 238000006467 substitution reaction Methods 0.000 claims 2
• 229940124597 therapeutic agent Drugs 0.000 claims 2
• 238000011830 transgenic mouse model Methods 0.000 claims 2
• 208000024827 Alzheimer disease Diseases 0.000 claims 1
• 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
• 208000023105 Huntington disease Diseases 0.000 claims 1
• 102000006386 Myelin Proteins Human genes 0.000 claims 1
• 108010083674 Myelin Proteins Proteins 0.000 claims 1
• 208000030768 Optic nerve injury Diseases 0.000 claims 1
• 208000018737 Parkinson disease Diseases 0.000 claims 1
• 208000006011 Stroke Diseases 0.000 claims 1
• 108700019146 Transgenes Proteins 0.000 claims 1
• 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
• 238000002266 amputation Methods 0.000 claims 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
• 230000000202 analgesic effect Effects 0.000 claims 1
• 238000010171 animal model Methods 0.000 claims 1
• 230000003376 axonal effect Effects 0.000 claims 1
• 230000003115 biocidal effect Effects 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 230000009918 complex formation Effects 0.000 claims 1
• 239000003246 corticosteroid Substances 0.000 claims 1
• 238000001727 in vivo Methods 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 201000006417 multiple sclerosis Diseases 0.000 claims 1
• 210000005012 myelin Anatomy 0.000 claims 1
• 230000007658 neurological function Effects 0.000 claims 1
• 230000007514 neuronal growth Effects 0.000 claims 1
• 239000002773 nucleotide Substances 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 230000001105 regulatory effect Effects 0.000 claims 1
• 208000020431 spinal cord injury Diseases 0.000 claims 1
• 208000024891 symptom Diseases 0.000 claims 1
• 230000009529 traumatic brain injury Effects 0.000 claims 1